Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Iovance Biotherapeutics (Silver).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

Share this video  

WCLC 2025 | The importance of identifying high-risk lung cancer patients for screening

Mattias Johansson, International Agency for Research on Cancer, Lyon, France, emphasizes the importance of risk stratification in identifying individuals with at least one or several risk factors for lung cancer, rather than screening the general population, including never-smokers. Biomarkers are needed to help identify high-risk individuals, as the number of never-smokers with sufficiently high risk to warrant screening is expected to be very low. This interview took place at 2025 World Conference on Lung Cancer (WCLC) in Barcelona, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Transcript

Well, I think the most important point is really that most people who never smoked have really very low risk of lung cancer. And there’s really no reason to go and screen just everyone who never smoked. So the risk stratification aspect of this to identify those with at least one or perhaps several risk factors for lung cancer is really crucial. But I think we also need perhaps biomarkers that can help identify those high-risk people...

Well, I think the most important point is really that most people who never smoked have really very low risk of lung cancer. And there’s really no reason to go and screen just everyone who never smoked. So the risk stratification aspect of this to identify those with at least one or perhaps several risk factors for lung cancer is really crucial. But I think we also need perhaps biomarkers that can help identify those high-risk people. If we look at the risk factors that we currently have a good understanding of, there would be very, very few never smokers who have a sufficiently high risk to be screened for lung cancer.

This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.

Read more...

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.